Resmed (RMD) Other Accumulated Expenses (2010 - 2021)

Resmed (RMD) has 12 years of Other Accumulated Expenses data on file, last reported at $12.3 million in Q2 2021.

• Quarterly Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $12.3 million (down 1.77% YoY) and the FY2021 annual result came in at $12.3 million, down 1.77% from the prior year.
• Other Accumulated Expenses retreated to $12.3 million in Q2 2021, from $12.5 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $12.5 million in Q2 2020 to a low of $10.9 million in Q2 2017.
• A 5-year average of $11.6 million and a median of $11.4 million in 2019 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2017 — Other Accumulated Expenses declined 13.98% — and 2020, when it climbed 9.64%.
• Tracing RMD's Other Accumulated Expenses over 5 years: stood at $10.9 million in 2017, then rose by 0.93% to $11.0 million in 2018, then increased by 3.6% to $11.4 million in 2019, then rose by 9.64% to $12.5 million in 2020, then slipped by 1.77% to $12.3 million in 2021.
• The last three Other Accumulated Expenses figures came in at $12.3 million (Q2 2021), $12.5 million (Q2 2020), and $11.4 million (Q2 2019), per Business Quant data.